The genetic toxicity effects of lamivudine and stavudine antiretroviral agents

Bibliography

• Balzarini J. Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives. Pharm World Sci 1994;16:113-26
   PubMed Web of Science ®Google Scholar
• Balzarini J. Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immunodeficiency virus activity of nucleoside reverse transcriptase inhibitors. Pharmacol Ther 2000;87:175-87
   PubMed Web of Science ®Google Scholar
• Schinazi RF, Hernandez-Santiago B, Hurwitz SJ. Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses. Antiviral Res 2006;71:322-34
   PubMed Web of Science ®Google Scholar
• Mitsuya H, Weinhold KJ, Furman FA, 3′-azido-3′-deoxythymidine (BW A509U): an ativiral agent that inhibits the inefectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 1985;82:7096-100
   PubMed Web of Science ®Google Scholar
• Styrt BA, Piazza-Hepp TD, Chikami GK. Clinical toxicity of antiretroviral nucleoside analogs. Antiviral Res 1996;31:121-35
   PubMed Web of Science ®Google Scholar
• Olivero OA. Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors. Environ Mol Mutagen 2007;48:215-23
   PubMed Web of Science ®Google Scholar
• Riddler SA, Anderson RE, Mellors JW. Antiretroviral activity of stavudine (2′,3′-didehydro-3′-deoxythymidine, d4T). Antiviral Res 1995;27:189-203
   PubMed Web of Science ®Google Scholar
• Coates JAV, Cammack N, Jenkinson HJ, The separated enantiomers of 2′-deoxi-3′-thiacytidine (BCH 189) both inhibit human immunodeficiency virus replication in vitro. Antimicrob Agents Chemother 1992;36:202-5
   PubMed Web of Science ®Google Scholar
• Schinazi RF, Chu CK, Peck A, Activities of the four optical isomers of 2′,3′-dideoxy-3′-thiacytidine (BCH 189) against human immunodeficiency virus Type 1 in human lymphocytes. Antimicrob Agents Chemother 1992;36:672-6
   PubMed Web of Science ®Google Scholar
• August EM, Birks EM, Prusoff WH. 3′-deoxythymidin-2′-ene permeation of human lymphocyte H9 cells by nonfacilitated diffusion. Mol Pharmacol 1991;39:246-9
   PubMed Web of Science ®Google Scholar
• Ho H-T, Hitchcock JM. Cellular pharmacology of 2′,3′-dideoxi 2′,3′-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus. Antimicrob Agents Chemother 1989;33:844-49
   PubMed Web of Science ®Google Scholar
• Dionne G. 3TC: a Canadian scientific sucess story. MJM 1999;5:60-5
   Google Scholar
• Chang CC, Skalski V, Zhou JH, Cheng Y. Biochemical pharmacology of (+) - and (-)-2′,3′-dideoxy-3′-thiacytidine as anti-hepatitis B Virus agents. J Biol Chem 1992;276:22414-20
   Google Scholar
• Gray NM, Marr CLP, Penn CR, The intracellular phosphorylation of (-)-2′-Deoxy-3′-Thiacytidine (3TC) and the incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase gamma. Biochem Pharmacol 1995;50:1043-51
   PubMed Web of Science ®Google Scholar
• Kukhanova M, Liu SH, Mozzherin D, L- and D-enantiomers of 2′,3′-dideoxycytidine 5′-triphosphate analogs as substrates for human DNA polymerases. J Biol Chem 1995;270:23055-59
   PubMed Web of Science ®Google Scholar
• Gray H, Wong TW. Purification and identification of subunit structure of the human mitochondrial DNA polymerase. J Biol Chem 1992;267:5835-41
   PubMed Web of Science ®Google Scholar
• Olson MW, Kaguni LS. 3′→5′ exonuclease in Drosophila mitochondrial DNA polymerase. J Biol Chem 1992;267:23136-42
   PubMed Web of Science ®Google Scholar
• Feng JY, Johnson AA, Johnson KA, Anderson KS. Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs. J Biol Chem 2001;276:23832-37
   PubMed Web of Science ®Google Scholar
• Anderson KS. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase. Biochim Biophys Acta 2002;1587:296-99
   PubMed Web of Science ®Google Scholar
• Lee H, Hanes J, Johnson KA. Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry 2003;42:14712-9
   Google Scholar
• Perry CM, Faulds D. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection. Drugs 1997;53:657-80
   PubMed Web of Science ®Google Scholar
• Becher F, Pruvost AG, Schlemmer DD, Significant levels of intracellular stavudine triphosphate are found in HIV-infected zidovudine-treated patients. AIDS 2003;17:555-61
   PubMed Web of Science ®Google Scholar
• Makinson A, Le Moing V, Kouanfack C, Safety of stavudine in the treatment of HIV infection with a special focus on resurce-limited settings. Expert Opin Drug Saf 2008;7:283-93
   PubMed Web of Science ®Google Scholar
• Johnson AA, Ray AS, Hanes J, Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polimerase. J Biol Chem 2001;44:40847-57
   Web of Science ®Google Scholar
• Schilling BE, Nelson DR, Proctor JE, The nonclinical toxicologic profile of stavudine. Curr Ther Res 1995;56:201-18
   Web of Science ®Google Scholar
• Ballardin M, Scarpato R, Kotwal GJ, Barale R. In vitro mutagenicity studies of the antiretrovirals AZT, didanosine, and 3TC and a plant antiviral extract Secomet-V derived from the Trifollium species. Ann NY Acad Sci 2005;1056:303-10
   PubMed Web of Science ®Google Scholar
• Wutzler P, Thust R. Genetic risks of antiviral nucleoside analogues – a survey. Antiviral Res 2001;49:55-74
   PubMed Web of Science ®Google Scholar
• Torres SM, Walker DM, Carter MM, Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations. Environ Mol Mutagen 2007;48:224-38
   PubMed Web of Science ®Google Scholar
• Carter MM, Torres SM, Cook DL Jr, Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid celss. Environ Mol Mutagen 2007;48:239-47
   PubMed Web of Science ®Google Scholar
• Von Tungeln LS, Williams LD, Doerge DR, Transplacental drug transfer and frequency of TK and HPRT lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine. Environ Mol Mutagen 2007;48:258-69
   PubMed Web of Science ®Google Scholar
• Von Tungeln LS, Hamilton LP, Dobrovolsky VN, Frequency of TK and HPRT lymphocyte mutants and bone marrow micronuclei in B6C3F1/Tk1/2 mice treated neonatally with zidovudine and lamivudine. Carcinogenesis 2002;23:1427-32
   PubMed Web of Science ®Google Scholar
• Bayram S, Topaktas M. Confirmation of the chromosome damaging effects of Lamivudine in in vitro human peripheral blood lymphocytes. Environ Mol Mutagen 2008;49:328-33
   PubMed Web of Science ®Google Scholar
• Franchi LP, Pentiado NHGR, Silva RN, Mutagenic and recombinagenic effects of lamivudine and stavudine antiretrovirals in somatic cells of drosophilla melanogaster. Food Chem Toxicol 2009;47:578-82
   PubMed Web of Science ®Google Scholar
• Olivero OA, Fernandez JJ, Antiochos BB, Transplacental genotoxicity of combined antiretroviral nucleoside analogue therapy in Erytrocebus patas monkeys. J Acquir Immune Defic Syndr 2002;30:323-9
   Google Scholar
• Yu M, Ward Y, Poirier MC, Olivero OA. Centrosome amplification induced by the antiretroviral nucleoside reverse transcriptase inhibitors lamivudine, stavudine, and didanosine. Environ Mol Mutagen 2009;50:718-24
   Google Scholar
• Kaur P, Singh R. In vivo interactive effect of garlic oil and vitamin E against stavudine induced genotoxicity in Mus musculus. Indian J Exp Biol 2007;45:807-11
   PubMed Web of Science ®Google Scholar
• Dobrovolsky VN, Shaddock JG, Mittelstaedt RA, Frequency of HPRT mutant lymphocytes and micronucleated erythrocytes in p53-haplodeficient mice treated perinatally with AZT and AZT in combination with 3TC. Environ Mol Mutagen 2007;48:270-82
   PubMed Web of Science ®Google Scholar
• Benhammou V, Warszawski J, Bellec S, Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitors. AIDS 2008;22:2165-77
   PubMed Web of Science ®Google Scholar
• Bonnet F, Lewden C, May T, Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004;101:317-24
   PubMed Web of Science ®Google Scholar
• Bishop AJR, Schiestl RH. Homologous recombination as a mechanism of carcinogenesis. Biochem Biophys Acta 2001;1471:M109-121
   PubMed Web of Science ®Google Scholar
• Bishop AJR, Schiestl RH. Role of homologous recombination in carcinogenesis. Exp Mol Pathol 2003;74:94-105
   PubMed Web of Science ®Google Scholar
• Olivero OA, Anderson L, Diwan B. Transplacental effects of 3′-azido-3′- deoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys. J Natl Cancer Inst 1997;69:1602-8
   Web of Science ®Google Scholar
• Olivero OA, Parikka R, Poirier MC, Vahakangas K. 3′- azido-3′- deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT. Mutat Res 1999;428:41-7
   PubMed Web of Science ®Google Scholar
• Meng Q, Olivero OA, Fasco MJ, Protocol team. Plasma and cellular markers of AZT metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving repartum NRTIs. Environ Mol Mutagen 2007;48:307-21
   PubMed Web of Science ®Google Scholar
• Bebenek K, Roberts JD, Kunkel TA. The effects of dNTP pool imbalances on frameshift fidelity during DNA replication. J Biol Chem 1992;267:3589-96
   PubMed Web of Science ®Google Scholar
• Palmer S, Cox S. Increased activation of the combination of 3′-azido-3′-deoxythymidine and 2′-deoxy-3′-thiacytidine in the presence of hydroxyurea. Antimicrob Agents Chemother 1997;41:460-4
   PubMed Web of Science ®Google Scholar
• Barile M, Valent D, Quagliariello E, Passarella S. Mitochondria as cell targets of AZT (zidovudine). Gen Pharmacol 1998;31:531-8
   PubMedGoogle Scholar
• Peter K, Gambertoglio JG. Intracellular phosphorylation of zidovudine (ZDV) and other nucleoside reverse transcriptase inhibitors (NRTI) used for human immunodeficiency virus (HIV) infection. Pharm Res 1998;15:819-25
   PubMed Web of Science ®Google Scholar
• Poirier MC, Olivero OA, Walker DM, Walker VE. Perinatal genotoxicity and carcinogenicity of antiretroviral nucleoside analog drugs. Toxicol Appl Pharmacol 2004;199:151-61
   PubMed Web of Science ®Google Scholar
• Phillips MD, Nascimbeni B, Tice RR, Shelby MD. Induction of micronuclei in mouse bone marrow cells: an evaluation of nucleoside analogues used in the treatment of AIDS. Environ Mol Mutagen 1991;18:168-83
   PubMed Web of Science ®Google Scholar
• Ames BN, Gurney EG, Miller JA, Bartsch H. Carcinogens as frameshift mutagens: metabolites and derivatives of 2-acetylaminofluorene and other aromatic amine carcinogens. Proc Natl Acad Sci USA 1972;69:3128-32
   PubMed Web of Science ®Google Scholar
• Pavanello S, Clonfero E. Biological indicators of genotoxic risk and metabolic polymorphisms. Mutat Res 2000;463:285-308
   PubMed Web of Science ®Google Scholar
• Collins AR, Oscoz AA, Brunborg G, The comet assay: topical issues. Mutagenesis 2008;23:143-51
   PubMed Web of Science ®Google Scholar
• Tice RR, Agurell E, Anderson D, Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen 2000;35:206-21
   PubMed Web of Science ®Google Scholar
• Fenech M, Morley AA. Cytokinesis-block micronucleus method in human lymphocytes: effect of in vivo ageing and low dose X-irradiation. Mutat Res 1986;161:193-8
   PubMed Web of Science ®Google Scholar
• Fenech M. The in vitro micronucleus technique. Mutat Res 2000;455:81-95
   PubMed Web of Science ®Google Scholar
• Fenech M. Cytokinesis-block micronucleus assay evolves into a “cytome” assay of chromosomal instability, mitotic dysfunction and cell death. Mutat Res 2006;600:58-66
   PubMed Web of Science ®Google Scholar
• Fenech M. Cytokinesis-block micronucleus cytome assay. Nat Protocol 2007;2:1084-104
   PubMed Web of Science ®Google Scholar
• Albertini RJ. HPRT mutations in humans: biomarkers for mechanistic studies. Mutat Res 2001;489:1-16
   PubMed Web of Science ®Google Scholar
• DeMarini DM, Brockman HE, de Serres FJ, Specific-locus mutations induced in eukaryotes (especially mammalian cells) by radiation and chemicals: a perspective. Mutat Res 1989;220:11-29
   PubMed Web of Science ®Google Scholar
• Clements J. Gene mutation assay in mammalian cells. In vitro testing protocols. Springer protocols, UK; 1995
   Google Scholar
• Buertedde JM, Takeda S. Sister chromatid exchange assay. Review and protocols in DT40 research. Spring Netherlands; 2006
   Google Scholar
• Andrade HHR, Reguly ML, Lehmann M. Wing somatic mutation and recombination test. In: Henderson DS, editor, Drosophila cytogenetics protocols–methods in molecular biology. Humana Press, Inc., Totowa; 2003. p. 389-412
   Google Scholar
• Graf U, Würgler FE, Katz AJ, Somatic mutation and recombination test in Drosophila melanogaster. Environ Mutagen 1984;6:153-18
   PubMedGoogle Scholar
• Kunz BA, Kohalmi SE, Kunkel TA, Deoxyribonucleoside triphosphate levels: a critical factor in the maintenance of genetic stability. Mutat Res 1994;318:1-64
   PubMed Web of Science ®Google Scholar